Researchers at Johns Hopkins University have developed digital twins of patients' hearts to improve treatment for ventricular tachycardia, showing promising results in a recent clinical trial. Johns Hopkins researchers have created digital twins of patients' hearts, enhancing treatment for ventricular tachycardia. Initial trials show promising results, indicating a potential shift in ...

Understanding the Context

Scientists have developed precise virtual replicas of patients' hearts, aiding doctors in treating ventricular tachycardia, a major cause of sudden cardiac arrest. Nasdaq: Adagio Medical Closes Financing of $19 Million Upfront; Positions Company to Advance Purpose-Built Technology for Treatment of Ventricular Tachycardia Adagio Medical Closes Financing of $19 Million Upfront; Positions Company to Advance Purpose-Built Technology for Treatment of Ventricular Tachycardia CURES provides a secure database for monitoring prescription drugs, aiding healthcare providers in preventing abuse and ensuring patient safety. Once the multi-step registration process is completed and access to CURES is granted, physicians are encouraged to check CURES as appropriate, or every six months, when prescribing controlled substances. CURES (Controlled Substance Utilization Review and Evaluation System) is a database of Schedule II, Schedule III, Schedule IV and Schedule V controlled substance prescriptions dispensed in California serving the public health, regulatory oversight agencies, and law enforcement.

Key Insights